These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2885007)

  • 21. Effect of beta adrenoreceptor blocking drugs on the responses of isolated rat mesenteric arteries.
    Risler NR; Ortego RE; Binia A
    Acta Physiol Lat Am; 1983; 33(2):171-80. PubMed ID: 6142581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of gastrointestinal mucosal glycoprotein synthesis by the beta-adrenergic blocking drug, practolol.
    Okine LK; Ioannides C; Parke DV
    Biochem Pharmacol; 1982 Jul; 31(13):2263-6. PubMed ID: 6127083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats.
    Davy M; Midol-Monnet M; Heimburger M; Wepierre J; Cohen Y
    J Pharmacol; 1986; 17(1):28-36. PubMed ID: 2872366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of anxiolytics and beta-receptor blocking drugs on novelty-oriented ("neophobic") behavior in the rat.
    Delini-Stula A; Hunn C
    Pharmacopsychiatry; 1988 Jul; 21(4):186-91. PubMed ID: 2905063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the beta-adrenergic blocking agent bupranolol on the plasma renin activity in normotensive rats].
    Placheta P; Singer E; Kraupp O
    Arzneimittelforschung; 1977; 27(11):2063-6. PubMed ID: 23790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical importance of lipid solubility in beta blockers.
    Neil-Dwyer G
    Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S19-22. PubMed ID: 6118118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic effects of adrenergic beta-blockers on agonistic behavior between resident and intruder mice.
    Yoshimura H; Kihara Y; Ogawa N
    Psychopharmacology (Berl); 1987; 91(4):445-50. PubMed ID: 2884688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice.
    Elonen E
    Med Biol; 1975 Aug; 53(4):231-7. PubMed ID: 241887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade.
    Heyma P; Larkins RG; Campbell DG
    Endocrinology; 1980 May; 106(5):1437-41. PubMed ID: 6102511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats.
    Ongini E; Milani S; Marzanatti M; Trampus M; Monopoli A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):114-9. PubMed ID: 1673471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different beta-blocking drugs and adrenaline on the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes.
    Aanderud S; Aarbakke J; Sundsfjord J
    Horm Metab Res; 1986 Feb; 18(2):110-3. PubMed ID: 2870969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a circadian-phase-dependency in 3H-dihydroalprenolol binding and cyclic AMP content in heart ventricles of L-D-synchronized rats.
    Lemmer B; Lang PH
    Pol J Pharmacol Pharm; 1984; 36(2-3):275-80. PubMed ID: 6089160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central regulation of blood eosinophilia by the beta-adrenergic system in rats.
    Szczeklik A; Podolec Z
    Int Arch Allergy Appl Immunol; 1976; 50(3):328-40. PubMed ID: 2558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of drug lipophilicity in release from intra-adipose and intramuscular injection sites.
    Kadir F; Zuidema J; Pijpers A; Vulto A; Verheijden JH
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():146-9. PubMed ID: 1687940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.